MARKET

ONCO

ONCO

Onconetix
NASDAQ
0.9765
-0.0033
-0.34%
After Hours: 0.9966 +0.0201 +2.06% 19:37 06/26 EDT
OPEN
0.9527
PREV CLOSE
0.9798
HIGH
1.010
LOW
0.9201
VOLUME
131.66K
TURNOVER
--
52 WEEK HIGH
270.00
52 WEEK LOW
0.8800
MARKET CAP
3.60M
P/E (TTM)
-0.0022
1D
5D
1M
3M
1Y
5Y
1D
Onconetix says Realbotix acquisition closing expected in H2 2026
PUBT · 4d ago
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga · 5d ago
Weekly Report: what happened at ONCO last week (0615-0619)?
Weekly Report · 6d ago
Oncopeptides Announces First Patient Enrollment In Clinical "Window-Of-Opportunity" Study Evaluating Proprietary Peptide Drug Conjugate Platform In Glioblastoma
Benzinga · 06/17 11:53
Weekly Report: what happened at ONCO last week (0608-0612)?
Weekly Report · 06/15 10:18
Onconetix files to sell 100M shares of common stock for holders
TipRanks · 06/09 10:06
ONCONETIX - REGISTERS UP TO 100 MLN SHARES FOR RESALE BY KEYSTONE CAPITAL PARTNERS - SEC FILING
Reuters · 06/09 10:01
Weekly Report: what happened at ONCO last week (0601-0605)?
Weekly Report · 06/08 10:14
More
About ONCO
Onconetix, Inc. is a commercial-stage biotechnology company focused on the research, development, and commercialization of solutions for men’s health and oncology. The Company owns Proclarix, an in vitro diagnostic test for prostate cancer approved for sale in the European Union under the In Vitro Diagnostic Regulation. Proclarix is an easy-to-use next generation protein-based blood test that can be done with the same sample as a patient’s regular Prostate-Specific Antigen (PSA) test.

Webull offers Onconetix Inc stock information, including NASDAQ: ONCO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ONCO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ONCO stock methods without spending real money on the virtual paper trading platform.